January 16 & 21: Learn about DoD Funding for Research in Cancer and Neurodegenerative Diseases
DoD Congressionally Directed Medical Research Program (CMDRP) Cancer Programs: Everything you need to know!
Join The Conafay Group on January 16 from 9-10am for a workshop that aims to provide insight about DoD Congressionally Directed Medical Research Program funding for Cancer. In previous years, CDMRP has had a wide range of cancer topics eligible for funding including, but not limited to: Breast Cancer, Melanoma, Ovarian Cancer, Prostate Cancer, Rare Cancer, Lung Cancer, Kidney Cancer, and Pancreatic Cancer. Future CDMRP programs are depended on the passing of the Congressional DoD Appropriations Bill. The overall objective is to give you tools that can help you be more competitive for research dollars for these programs. From this presentation, you will hear about CDMRP, what kinds of research the program is interested in, and how the system works.
DoD Congressionally Directed Medical Research Program (CMDRP) Neurodegenerative Diseases: Everything you need to know!
Join The Conafay Group January 21 from 10-11am for a workshop that aims to provide insight about DoD Congressionally Directed Medical Research Program funding for Neurodegenerative Diseases. In previous years, CDMRP has had a wide range of neuro topics eligible for funding including, but not limited to: Alzheimer’s, Amyotrophia Lateral Sclerosis (ALS), Duchenne Muscular Dystrophy, Autism, Epilepsy, Multiple Sclerosis, Parkinson’s, Traumatic Brain Injury, and Psychological Health. Future CDMRP programs are depended on the passing of the Congressional DoD Appropriations Bill. The overall objective is to give you tools that can help you be more competitive for research dollars for these programs. From this presentation, you will hear about CDMRP, what kinds of research the program is interested in, and how the system works.
Speaker
Erik Wolf
Vice President
The Conafay Group
Dr. Erik Wolf has over 20 years of experience in medical research and development (R&D), with special expertise in military medical research. For the Conafay Group, he provides expertise in federal R&D programs as well as partnerships across government, academia, and industry.
Dr. Wolf spent 6 years (2015-2021) at the U.S. Army Medical Research and Development Command (USAMRDC). During his tenure, he was the Program Area Manager for the Neuromusculoskeletal Injury Rehabilitation Portfolio within the Clinical and Rehabilitative Medicine Research Program (CRMRP), where his responsibilities included the strategic planning and programmatic management of R&D efforts towards returning Warfighters to duty following musculoskeletal injury and achieving the highest possible function and quality of life following limb trauma and amputation. For a time, Dr. Wolf also served as the acting Civilian Deputy for CRMRP. Dr. Wolf completed detail assignments within the Plans, Programs, Analysis, and Evaluation (PPA&E) Directorate and the Office of the Principal Assistant for Research and Technology (OPAR&T) and served for one year as the Acting Director for the Medical Simulation and Information Sciences Research Program. These roles and responsibilities provided a broad range of understanding related to military medical R&D and valuable interactions with academic, industry and other federal partners.
Prior to his time at USAMRDC, Dr. Wolf worked as the Senior Research Biomedical Engineer for the Extremity Trauma and Amputation Center of Excellence stationed at Walter Reed National Military Medical Center. There his research focused on optimizing function and performance of Warfighters with limb trauma and amputation.
